Processa Pharmaceuticals Inc.

10/02/2024 | Press release | Distributed by Public on 10/02/2024 14:13

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer